Pathfinder Cell Therapy (PFND) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PFND Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartStock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePathfinder Cell Therapy, Inc. (PFND)finance.yahoo.com - October 10 at 11:08 PMFinal Results From PATHFINDER Study of GRAIL's Multi-Cancer Early Detection Blood Test Published in The Lancetbenzinga.com - October 5 at 8:31 PMNew PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testingbusinesswire.com - June 3 at 7:12 PMBluebird Sickle Cell Gene Therapy Falls Short of High Expectationsthestreet.com - May 11 at 11:54 PMStem Cell Therapy Market Size to Surpass USD 921.12 Million with CAGR of 17.3% by 2030, Share, Growth, Demand, Global Trends and Competitive Outlookfinance.yahoo.com - March 8 at 9:11 PMPathfinder Cell Therapy Increuters.com - October 12 at 9:25 AMCORRECTING and REPLACING GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022apnews.com - September 12 at 4:46 AMGRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022apnews.com - September 11 at 12:27 PMGRAIL to Present Final Multi-cancer Early Detection Data From the Interventional PATHFINDER Study at ESMO Congress 2022apnews.com - September 8 at 7:13 PMPathfinder Cell Therapy Inc (PFND)nasdaq.com - January 24 at 12:32 AM Get Pathfinder Cell Therapy News Delivered to You Automatically Sign up to receive the latest news and ratings for PFND and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. PFND Media Mentions By Week PFND Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFND News Sentiment▼0.000.32▲Average Medical News Sentiment PFND News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFND Articles This Week▼00▲PFND Articles Average Week Get Pathfinder Cell Therapy News Delivered to You Automatically Sign up to receive the latest news and ratings for PFND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BNKL News Today CLPBY News Today TGIFF News Today FFNTF News Today ABSCF News Today ACONW News Today ACRHF News Today ACRDF News Today ADMT News Today ALEAF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PFND) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pathfinder Cell Therapy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
